Dialysis Device and Concentrates Market Report Suite for the US | 2017-2023 | MedSuite | Hemodialysis and Peritoneal Dialysis Machines, Dialysis Catheters, Dialysis Concentrates, Dialyzers, Dialyzer Reprocessing Machines, Hemodialysis Bloodline and Tubing Sets, AV Fistula Needles, AV grafts, Declotting Devices, Introducer Sheaths and Guidewires and Water Treatment Systems

Dialysis Device and Concentrates Market Report Suite for the US | 2017-2023 | MedSuite | Hemodialysis and Peritoneal Dialysis Machines, Dialysis Catheters, Dialysis Concentrates, Dialyzers, Dialyzer Reprocessing Machines, Hemodialysis Bloodline and Tubing Sets, AV Fistula Needles, AV grafts, Declotting Devices, Introducer Sheaths and Guidewires and Water Treatment Systems

0

The full report suite on the U.S. market for dialysis includes hemodialysis and peritoneal dialysis machines, dialysis catheters, dialyzers, dialyzer reprocessing machines, hemodialysis bloodline and tubing sets, AV fistula needles, AV access grafts, declotting devices, introducer sheaths and guidewires and water treatment systems. The dialysis patient population has been increasing since 2013 and is projected to continue increasing over the forecast period. Notable trends include shifts between hemodialysis patients and peritoneal dialysis patients as well as the rate of transition from in-center treatment options to personal, home treatment.

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 10/1/2016
  • Pages: 237
  • Type: MedSuite

Major Segments Covered in the Dialysis Device Market Report Suite

Overall, the dialysis market was valued at $1,814.1 billion in 2016. This is expected to increase over the forecast period at a CAGR of 2.1% to reach $2,098.2 billion.

The full report suite on the U.S. market for dialysis includes hemodialysis and peritoneal dialysis machines, dialysis catheters, dialysis concentrates, dialyzers, dialyzer reprocessing machines, hemodialysis bloodline and tubing sets, AV fistula needles, AV grafts, declotting devices, introducer sheaths and guidewires and water treatment systems.

While this report suite contains all US Dialysis Device data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the Dialysis Device market research that you need. You can view all these included reports and segmentation here:

  • US Market Overview for Dialysis Devices 2017 – MedView: Gives an easily accessible view of all dialysis device markets and trends, and aggregates the data together for a picture of the total US market.
  • US Procedure Numbers for Dialysis Devices 2017 – MedPro: Using a number of databases, internal and external, we’re able to provide you with the total volume of dialysis device procedures being performed for each of the markets mentioned in this suite of reports.
  • US Market Report for Dialysis Machines 2017 – MedCoreA hemodialysis machine performs the critical tasks and drives hemodialysis treatments. A hemodialysis machine pumps blood from the body of the patient through a system of bloodlines and into the dialyzer. Dialysis fluids absorb toxins and excess water filtered out of the blood and then removes them from the body. The dialysis fluids are entered into the dialyzer through a separate cycle. Hemodialysis machines mix and monitor the dialysate used in each treatment. Dialysate is the dialysis fluid that serves to remove dangerous and unwanted waste products from the patient’s blood. A dialysis machine also adds an anti-coagulant drug into the blood.
  • US Market Report for Dialysis Catheters 2017 – MedCore: The dialysis catheter market is composed of short-term (acute) hemodialysis, long-term (chronic) hemodialysis and peritoneal dialysis (PD) catheters. The largest segment in the total dialysis catheter market in 2016 was represented by long-term hemodialysis catheters. Growth in the long-term hemodialysis catheter segment was driven by increases in the conventional long-term hemodialysis and the antimicrobial long-term hemodialysis sub-segments. Moderate growth in the value of the total dialysis catheter market is expected to persist over the forecast period. However, the shift toward fistula use in the U.S. will continue to hinder growth in the value of the total dialysis catheter market.
  • US Market Report for Dialysis Concentrates 2017 – MedCore: There are two main types of concentrates for hemodialysis: acid and bicarbonate (base). Treated water is mixed with acid and bicarbonate concentrates to form the dialysis fluid (dialysate). Hemodialysate (dialysate) is the fluid and solutes that flows through the dialyzer during a hemodialysis process. After the combination of the bicarbonate concentrate, acid concentrate and water, the final dialysate can contain two or three buffer components, which depend on the acid concentrate used. The buffers are bicarbonate from the bicarbonate concentrate, citrate and/or acetate from the acid concentrate.
  • US Market Report for Dialyzers 2017 – MedCore: In the process of hemodialysis, the dialyzer performs the essential function of the kidney. During a hemodialysis treatment, the dialyzer will clean and remove the toxic substances from the blood. Blood can only be cleaned physically, not chemically. The patient’s blood is essentially filtered inside the dialyzer, and is channeled through the hollow fibers of the dialyzer. The walls of the hollow fibers consist of an ultra-thin membrane and various physical processes enable the removal of harmful molecules, while the critical elements of the blood are retained. The more exact a dialyzer and its membrane are at separating the important molecules from the harmful ones, the more effective the hemodialysis treatment will be.
  • US Market Report for Dialyzer Reprocessing Machines 2017 – MedCore: Each hemodialysis treatment undergone by a patient requires the use of a dialyzer. The dialyzer employed by each treatment can be either a single-use or a reuse dialyzer. A single-use dialyzer will be adequate for a single treatment, after which it will be disposed of. A reuse dialyzer is adequate for use on multiple treatments of the same patient. In order to be reused, a reuse dialyzer needs to be reprocessed. The procedure of reprocessing comprises cleaning, testing, filling the dialyzer with sterilant, inspecting, labeling, storing and rinsing the dialyzer before it is used for the next treatment. During the reprocessing, a reuse dialyzer also undergoes a volume test to ensure that the fibers that transport the blood are not occluded, and a pressure test to ensure that the fibers of the dialyzer are not broken. All these steps are performed by automatic equipment, which is the role of the dialyzer reprocessing machine. After reprocessing, the reuse technician will visually inspect the dialyzer to ensure that all critical aspects are up to standard. If the dialyzer passes the final inspection, it will then be labeled, which will show the patients name, the number of times they have used the dialyzer, the date and time of its last reprocessing and the initials of the individual that reprocessed the dialyzer.
  • US Market Report for Hemodialysis Bloodlines and Tubing Sets 2017 – MedCoreBloodlines, or a blood tubing set, are required for every single hemodialysis treatment. They fulfill the critical role of connecting the patient to the hemodialysis machine. The blood is taken from the patient and sent through the bloodlines to the hemodialysis machine, where the blood is cleansed of impurities in the dialyzer. The blood is then pumped out of the hemodialysis machine, through the bloodlines and back into the patient.
  • US Market Report for AV Fistula Needles 2017 – MedCore: An AV fistula needle enables access to the patient’s circulatory system and permits the flow of blood from the patient, to the dialyzer’s blood compartment and then back into the patient’s bloodstream. An AV fistula needle is used for patients with either an AV fistula or an AV graft; however, they are not required for patients implanted with a dialysis catheter.
  • US Market Report for AV Grafts 2017 – MedCore: Arteriovenous (AV) is the most common method of access for hemodialysis treatment in patients that are suffering from end-stage renal disease (ESRD). AV access can be achieved via either AV fistula or AV graft. The fistula can be made in an extremity, typically in the forearm, where an artery and vein are surgically connected. This connection matures and strengthens over a period of four to six weeks. Native fistulae offer the best patency and durability, in addition to limiting complications such as post-dialysis bleeding and infection. A native fistula is the preferred access technique.
  • US Market Report for Declotting Devices 2017 – MedCore: Lumen stenosis can occur due to the accumulation of thrombosis or plaque particles in a similar manner to peripheral arterial disease. The accumulation of these plaque particles has also been shown to cause calcification. Lumen stenosis is a considerable problem for both AV access surgical grafts and native fistulae because they have poor vessel patency. Due to their tendency to acquire blockages, AV access surgical grafts will require revascularization twice a year, and native fistulae will need to be cleared at least once a year.
  • US Market Report for Introducer Sheaths and Guidewires 2017 – MedCore: The guidewire market can best be segmented into standard (non-hydrophilic) and hydrophilic guidewires. Standard guidewires are the predominant type because they can handle more pressure than their hydrophilic counterparts. Due to this property, standard guidewires can handle heavy-duty manipulations and maneuvers. Standard guidewires are produced in a variety of configurations based on shape and size. These variants range in price depending on characteristics such as size and flexibility. When more flexibility and fluidity are required, hydrophilic guidewires are used. Hydrophilic guidewires are typically manufactured in a three-step layering process.
  • US Market Report for Water Treatment 2017 – MedCore: A hemodialysis patient will be exposed to between 400 to 600 liters of water per week, through their dialysis treatments. To put this in perspective, a person with normal kidney function will be exposed to approximately 15 liters of water per week. To compound that fact, the intestinal barrier and stomach acid of a person offers protection from contaminated water better than the barrier imposed by the membrane of a dialyzer. Furthermore, a functioning kidney can further protect a normal individual by eliminating contaminants in the water; such protection is absent for a hemodialysis patient. As a result, the regulations that govern the purity of drinking water are not sufficient for patients on hemodialysis.
  • OTHER INFORMATION – Company Profiles and SWOT, Disease Overviews, & Related Press Releases from Top Competitors

Buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More

Dialysis Device Market Trends

The market for dialysis machines grew 3.9% in 2016. Due to a growing patient population and growth in both the home hemodialysis (HHD) and peritoneal dialysis (PD) markets, the market for dialysis machines is expected to increase at a CAGR of 3.5% over the forecast period. Despite the Fistula First Breakthrough Initiative and a trend toward AV fistula usage, dialysis catheters will still be the most beneficial form of access for the hemodialysis patient population. Catheters will also continue to be used for new hemodialysis patients, while their AV fistula is prepared. The dialysis catheter market is expected to increase at a CAGR of 3.1% over the forecast period.

Dialysis Device Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2023, and Historical Data to 2013
  • Market Drivers & Limiters for Each Dialysis Device Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Dialysis Device Procedure Volumes
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors

Dialysis Device Companies Analyzed

Fresenius, DaVita and U.S. Renal Care are the industry leaders for the provision of dialysis services within the United States. Fresenius, however, is the only manufacturer than owns and operates their own clinics equipped with their own supplies. This has afforded Fresenius an exceptional lead in the dialysis market. Fresenius offers products in five of the eleven segments of the 2016 U.S. dialysis market including dialysis machines, dialysis concentrates, dialyzers, hemodialysis bloodline and tubing sets and AV fistula needles.

History of Our Dialysis Device Market Research

We’ve been doing market research for medical devices for over a decade. We specialize in it, and the dialysis device market was one of our original reports that helped build trust in our research and methodology. We have built relationships with the top competitors in the dialysis device market so that we can gather proprietary information in confidence to assure more accurate research – that our partners and clients then benefit from.

Because we’re a third party researcher, we have the ability to reach well into the top dialysis device companies and look at a multi-angle approach to our research. Not only do we consider financial filings, we conduct interviews, use hospital and procedural databases, and our own history of research to create a picture of the market that’s incredibly accurate.

Our clients have used our dialysis device market research for years to strategize new markets to break into, submit SEC filings, decide sales and marketing strategies, plan acquisitions and product launches, and provide a 3rd party source to show investors, boards, and senior executives.



The "US Market Report Suite for Dialysis Device and Concentrates 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Fresenius
Baxter
Rockwell Medical
Medivators
MarCor
Medisystems
B. Braun
Nipro Medical
Asahi Kasei Medical
Medcomp
Medtronic
Teleflex Medical
AmeriWater
Merit Medical Systems
C.R. Bard
Edwards Lifesciences
NxStage Medical
AngioDynamics
Tarumo
MEDRAD
W.L. Gore
Cook Medical
Kawasumi Laboratories
Lemaitre Vascular Inc.
Cordis
Boston Scientific
Abbott
Argon Medical
Atrium
Artegraft
Angelini Pharma Inc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link